Seer (SEER) Current Deferred Revenue (2020 - 2026)
Seer (SEER) recorded quarterly Current Deferred Revenue of $334000.0 in Q1 2026, down 2.05% quarter-over-quarter from $341000.0 in Q4 2025, and down 24.6% on a YoY basis from $443000.0 in Q1 2025.
Seer (SEER) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Seer's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $334000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 24.6% year-over-year to $334000.0; the TTM figure through Mar 2026 stood at $334000.0 (down 24.6% YoY), while the FY2025 annual figure was $341000.0, down 25.22% from the prior year.
- Current Deferred Revenue was $334000.0 for Q1 2026 at Seer, down from $341000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $560000.0 in Q2 2025 to a low of $133000.0 in Q1 2022.
- Historically, Current Deferred Revenue has averaged $336235.3 across 5 years, with a median of $329000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue sank 64.63% in 2022, then soared 141.38% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $133000.0 in 2022, then surged by 103.01% to $270000.0 in 2023, then jumped by 68.89% to $456000.0 in 2024, then fell by 25.22% to $341000.0 in 2025, then fell by 2.05% to $334000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $334000.0 (Q1 2026), $341000.0 (Q4 2025), and $496000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 496,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 413,000.00 |
| Jun 30, 2024 | 232,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 230,000.00 |
| Jun 30, 2023 | 286,000.00 |
| Mar 31, 2023 | 306,000.00 |
| Dec 31, 2022 | 133,000.00 |
| Sep 30, 2022 | 325,000.00 |
| Jun 30, 2022 | 429,000.00 |
| Mar 31, 2022 | 133,000.00 |
| Dec 31, 2021 | 376,000.00 |
| Sep 30, 2021 | 376,000.00 |
| Jun 30, 2021 | 376,000.00 |